Subcutaneous placebo clinical trials

Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness

This study looks at how a drug similar to a natural body chemical (GLP-1) affects brain responses to insulin in people of different weights. Researchers use special brain scans and tests to understand if this drug changes how the brain uses insulin and influences eating habits.